CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities
Net loss	$ (16,543,616)	$ (7,908,777)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	36,408	15,319
Amortization of ROU asset	88,738	77,383
Unrealized gain on investments	(29,664)	(5,474)
Realized gain on investments	(40,911)	(6,881)
Amortization of debt discount	500,937	1,777,505
Change in fair value of derivative liability	970,866	1,642,697
Stock-based compensation	6,069,560	0
Write-off of other receivable	1,064	0
Changes in operating assets and liabilities:
Accrued interest	516,445	397,517
Other receivable	0	(1,064)
Accounts payable and accrued liabilities	234,332	255,194
Due to related party	(6,833)	0
Deferred income	(195,800)	(52,200)
Grant payable	354,967	0
Prepaid expenses	(96,116)	19,868
Lease liability	(87,749)	(75,801)
Net cash used in operating activities	(8,227,372)	(3,864,714)
Cash flows from investing activities
Additions to long-term deposits	(5,945,911)	(550,000)
Purchase of property and equipment	(150,763)	0
Purchase of short-term investments	(16,560,779)	(1,295,252)
Redemption of short-term investments	2,363,696	589,200
Net cash used in investing activities	(20,293,757)	(1,256,052)
Cash flows from financing activities
Repayment of related party notes payable	(100,000)	(45,000)
Issuance costs for convertible debentures	0	(19,950)
Proceeds from convertible debentures	0	743,400
Proceeds from Regulation A financing	7,247,931	10,690,243
Proceeds from Initial Public Offering	22,061,857	0
Cash paid for financing costs	(3,157,638)	(841,337)
Net cash provided by financing activities	26,052,150	10,527,356
(Decrease) increase in cash	(2,468,979)	5,406,590
Cash and restricted cash, beginning of year	7,100,699	1,694,109
Cash and restricted cash, end of year	4,631,720	7,100,699
Cash	4,581,128	7,050,610
Restricted cash	50,592	50,089
Total cash and restricted cash, end of year	4,631,720	7,100,699
Supplemental cash flow information
Income taxes paid	0	0
Interest paid	39,539	89,152
Supplemental disclosure of non-cash investing and financing activities
Right of use asset additions	20,372	0
Right of use asset modifications	303,611	0
Shares issued for common stock subscribed	1,870,643	0
Deferred financing costs recognized as share issuance costs	105,703	0
Notes and interest payable converted into shares	1,451,480	0
Convertible debentures and derivative liabilities converted into shares	13,767,137	0
Initial derivative liability from issuance of convertible notes	$ 0	$ 475,909